ALLOPHARM is a biotechnology company

Established in 2004 with the support of the Foundation for the Promotion of Innovation

Studying insect immune systems as the basis of scientific discoveries

The creation of technologies for the introduction of newly acquired knowledge into modern medicine

Cooperation with Russian and foreign institutions in the field of developing new methods of treatment and disease prevention

Pull the arrow button to the side

The results of our studies were reviewed by the world scientific community and published (leads to our publications) in the internationally rated journals

PNAS, PLoS ONE, Journal of Biological Chemistry, International Immunopharmacology and others

All developments are protected by patents (leads to intellectual property), trademarks and know-how are designed in accordance with the current legislation of the Russian Federation. Allopharm also has international patents.

History

The Allopharm Scientific Group took part in the development, clinical trials and promotion of the alloferon-based antiviral drug Allokin-Alfa (author Chernysh SI). Allokin-alpha is the only injection in the world based on components of insect immune systems.

Our team

Shevchenko Olga

CEO

Biologist, financier

Chernysh Sergey

Founder

Doctor of Biological Sciences
Head of the Laboratory of Insect Biopharmacology and Immunology of SPBU

Chernysh Natalia

Founder

Biologist

All team